Eurofins Biomnis is a provider of pathology diagnostic testing and offers reliable and timely services delivered by dedicated and fully trained staff. The company’s microbial testing range includes panels for sexually transmitted diseases (Atopobium, Chlamydia, Gardnerella, Mycoplasma, Neisseria gonorrhoeae, Trichomonas vaginalis, Ureaplasma urealyticum), bacterial and viral infectious diseases (HIV, hepatitis B and C viruses, human papillomavirus, CMV, EBV, parvovirus, , measles, influenza, pneumonia), specialised parasitology (toxocariasis, amoebiasis, ascariasis, filariasis) and emerging microbial diseases such as Zika and dengue fever. By ensuring that every test is performed to the highest standard every time, Eurofins Biomnis can help its customers make better informed healthcare decisions for patients. www.eurofins.co.uk/biomnis/our-services/medical-testing/microbiology/
Other News
Latest Issues
Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...
LabMedUK26
The Eastside Rooms conference centre, Birmingham
8-10 June, 2026
London Biotechnology Show
Excel, London
9-10 June, 2026
Weqas Annual Laboratory Conference 2026
St Andrew’s Stadium, Birmingham
11th June 2026
European Human Genetics Conference
Svenska Mässan, Gothenburg, Sweden
13-16 June, 2026
UK NEQAS webinar: Cancer – Tumour Clonality and Metastasis
Online
16 June, 2026